On January 23, 2024, Better Therapeutics, Inc. closed the transaction. The company issued 1,471,453 shares at an issue price of $0.1699 per share for the gross proceeds of $249,999.8647 pursuant to Regulation D and included participation from single investor.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0101 USD | +3.90% | +20.24% | -94.82% |
May. 22 | Click Therapeutics, Inc. acquired Assets of Better Therapeutics, Inc.. | CI |
Mar. 21 | Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.82% | 532K | |
+46.63% | 56.65B | |
-6.64% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.23% | 26.75B | |
-21.63% | 19.03B | |
+0.62% | 12.28B | |
+23.63% | 12.26B | |
+27.68% | 12.04B |
- Stock Market
- Equities
- BTTX Stock
- News Better Therapeutics, Inc.
- Better Therapeutics, Inc. announced that it has received $0.25 million in funding